Suvorexant to Reduce Symptoms of Nicotine Use
NCT04234997
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Smoking Cessation
Interventions
DRUG:
Suvorexant 20 mg
DRUG:
Suvorexant 0mg
Sponsor
The University of Texas Health Science Center, Houston